Sign in Subscribe
Cancer

Personalized Cancer Screening Holds Promise for Effective Prevention

Strategic Insights

— 2 min read

A study published in Frontiers in Oncology has explored the potential of personalized cancer screening guided by genomic information. The research, conducted by a team of scientists from the Kanagawa Cancer Center in Yokohama, Japan, suggests that current approaches to cancer prevention face challenges due to the low risk associated with most genetic variants and limited experience in genetic counseling for healthy individuals. The study proposes a feasibility study that employs a germline cancer genomic panel of 30-80 high-risk cancer genes to identify individuals with pathogenic variants.

Key Takeaways:

  • The study highlights the potential of personalized cancer screening guided by genomic information for effective cancer prevention.
  • Current approaches to cancer prevention face challenges due to the low risk associated with most genetic variants and limited experience in genetic counseling for healthy individuals.
  • The study proposes a feasibility study that employs a germline cancer genomic panel of 30-80 high-risk cancer genes, such as BRCA1 and BRCA2, to identify individuals with pathogenic variants.
  • Genetic counseling will be conducted by certified medical doctors and genetic counselors utilizing the Kanagawa Prospective 'ME-BYO' Cohort Study.
  • The initiative seeks to adapt hereditary cancer counseling practices to preventive medicine, addressing the differences in counseling between clinical and preventive settings.
  • The research aims to establish a framework for personalized cancer screening, contributing to future guidelines for identifying individuals at high risk of hereditary cancers.
  • The study aims to bridge the gap between genomic research and practical preventive medicine, paving the way for personalized cancer screening strategies based on genetic information.
  • The authors include Hiroto Narimatsu, Kaname Watanabe, Ann Sato, Eri Haneda, Masumi Okamoto, Haruka Nakada, and Sho Nakamura.

Statistics:

  • 30-80 high-risk cancer genes will be included in the germline cancer genomic panel. (Frontiers in Oncology)
  • The research aims to establish a framework for personalized cancer screening, contributing to future guidelines for identifying individuals at high risk of hereditary cancers. (Frontiers in Oncology)
  • The study proposes a feasibility study that employs a germline cancer genomic panel to identify individuals with pathogenic variants. (Frontiers in Oncology)
  • The research aims to bridge the gap between genomic research and practical preventive medicine, paving the way for personalized cancer screening strategies based on genetic information. (Frontiers in Oncology)
  • 0.5% of the population in the United States is estimated to have BRCA1 and BRCA2 mutations. (Source not explicitly stated)
  • 15.0 (front number) is the ID of the article published in Frontiers in Oncology. (Frontiers in Oncology)

Sources:

  • Frontiers in Oncology, 2025,15. (Frontiers in Oncology - http://www.frontiersin.org/oncology)
  • NewsRx. Researchers from Kanagawa Cancer Center Detail Findings in Personalized Medicine (Personalized preventive medicine using genomic information: future perspective and corresponding research plan). Health & Medicine Week. June 27, 2025; p 3893.

Read more